Power Law company profile

Epizyme

Biotech & Life Sciences · Cambridge, United States · Founded 2007 · IPO 2013 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$249M

Market cap · 2026

Revenue

$74M

Latest reported FY

Investors

8 investors on Epizyme's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

Series B+ 4 investors entered at this stage

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo